Search Results - "Baston-Rey I"

Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.

Authors: Mesonero F Zabana Y Fernández-Clotet A et al.

Source: Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2026 Feb 18; Vol. 19, pp. 17562848261422373. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Therap Adv Gastroenterol Subsets: PubMed not MEDLINE

A systematic review of machine learning-based prognostic models for acute pancreatitis: Towards improving methods and reporting quality.

Authors: Critelli, Brian Hassan, Amier Lahooti, Ila et al.

Source: PLoS Medicine. 2/24/2025, Vol. 22 Issue 2, p1-19. 19p.

Autotaxin Induces S1P/S1PR1 Signaling to Affect Th17/Treg Cell Balance and Exacerbate Intestinal Inflammation in Colitis.

Authors: Xiao, Siqi Peng, Kaixin Li, Congxin et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 6, p2861. 17p.

Letter: the under-treatment and under-diagnosis of pancreatic exocrine insufficiency in chronic pancreatitis and pancreatic cancer is just the tip of the iceberg-authors' reply.

Authors: Forsmark CE Yadav D

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Aug; Vol. 52 (4), pp. 744.

Publication Type: Letter; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.

Authors: García, María José Rivero, Montserrat Fernández-Clotet, Agnès et al.

Source: Journal of Crohn's & Colitis. Jan2024, Vol. 18 Issue 1, p65-74. 10p.

Development and Validation of a Clinical Decision Support Tool to Predict Disease Progression in Crohn's Disease Treated with Ustekinumab.

Authors: Yao, Lingya Cao, Yushu Bai, Chenhao et al.

Source: Journal of Clinical Medicine. Nov2025, Vol. 14 Issue 22, p7919. 13p.

Cell-Free DNA Hypermethylation in Patients with Acute Pancreatitis.

Authors: Al-Mashat, Hassan Baddoo, Daniel Roger Lundbye-Christensen, Søren et al.

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10792. 16p.

Creeping fat is associated with transmural healing in patients with Crohn's disease receiving ustekinumab.

Authors: Zhang, Fangling Guo, Minyi Zhu, Pan et al.

Source: Insights into Imaging. 10/4/2025, Vol. 16 Issue 1, p1-12. 12p.

From Inflammation to Dysfunction: The Impact of a First Acute Pancreatitis Episode on Pancreatic Function.

Authors: Balaban, Marina Balaban, Daniel Vasile Enache, Iulia et al.

Source: Journal of Clinical Medicine. Jul2025, Vol. 14 Issue 14, p4932. 17p.

Moderating effects of resilience and depression on social support and life satisfaction in patients with IBD: a cross-sectional study.

Authors: Shen, Jia-Mei Zhang, Yan Xie, Ying et al.

Source: Scientific Reports. 7/2/2025, Vol. 15 Issue 1, p1-10. 10p.

Impact of Acute Pancreatitis Aetiology on Long-Term Outcomes Following a First Episode of Acute Pancreatitis: A Systematic Review and Meta-Analysis.

Authors: Ndaba, Emmanuel Malesela Omoshoro-Jones, Jones A. O. Nweke, Ekene Emmanuel et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 9, p3388. 16p.

Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU.

Authors: Mesonero F Zabana Y Fernández-Clotet A et al.

Corporate Authors: Mesonero F Zabana Y Fernández-Clotet A et al.

Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2025 Feb; Vol. 57 (2), pp. 566-573. Date of Electronic Publication: 2024 Oct 24.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.

Authors: Chaparro, María Baston-Rey, Iria Fernández Salgado, Estela et al.

Source: Journal of Clinical Medicine. Aug2022, Vol. 11 Issue 15, p4518-4518. 17p.

Advanced Therapies for Inflammatory Bowel Disease and Risk of Skin Cancer: What's New?

Authors: Bencardino, Sarah Bernardi, Francesca Allocca, Mariangela et al.

Source: Cancers. May2025, Vol. 17 Issue 10, p1710. 15p.

Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment.

Authors: Bokemeyer, Bernd Plachta-Danielzik, Sandra Gilman, Elena et al.

Source: Journal of Crohn's & Colitis. Apr2025, Vol. 19 Issue 4, p1-13. 13p.

Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.

Authors: Bertin, Luisa Barberio, Brigida Gubbiotti, Alessandro et al.

Source: Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 6, p1539. 16p.

In Vitro Preliminary Evaluation of a New Rifamycin In Situ Gelling Formulation for Pouchitis Treatment.

Authors: Aiello, Caterina Quattrocchi, Cinzia Musumeci, Rosario et al.

Source: Microbiology Research. Feb2025, Vol. 16 Issue 2, p44. 10p.

Diagnosis and Management of Acute Pancreatitis.

Authors: Mittal, Nitish Oza, Veeral M. Muniraj, Thiruvengadam et al.

Source: Diagnostics (2075-4418). Feb2025, Vol. 15 Issue 3, p258. 16p.

Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study.

Authors: Chiu, Horng-Yih Kuo, Chia-Jung Lai, Ming-Wei et al.

Source: BMC Gastroenterology. 12/31/2024, Vol. 24 Issue 1, p1-8. 8p.

Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut–Kidney Axis.

Authors: de Sire, Roberto La Mantia, Alessia Bonacci, Livio et al.

Source: Life (2075-1729). Dec2024, Vol. 14 Issue 12, p1541. 15p.